-
Colossal Biosciences develops radical new genetic tools and technologies to advance the fields of de-extinction, species restoration, and human healthcare for the preservation of biodiversity on Earth.
-
The World Economic Forum announced its selection of the 100 most promising Technology Pioneers of 2022 – companies tackling issues from sustainability and climate change to healthcare and more
Colossal Biosciences, a breakthrough biosciences and genetic engineering company, was selected as one of the World Economic Forum’s “Technology Pioneers”. Colossal has invented a working model of de-extinction and is the first to leverage CRISPR and other gene editing technologies for the purposes of species de-extinction, beginning with the woolly mammoth. Genetic tools and technologies developed by Colossal will also have the potential to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare.
Latest Aithority Insights: Cloudflare Appoints Carlos Torales Montero as VP, Head of Sales Latin America
“We’re honored to share this distinction with fellow inventors working to preserve and protect life on Earth”
The World Economic Forum’s Technology Pioneers are early to growth-stage companies from around the world that are involved in the use of new technologies and innovation that are poised to have a significant impact on business and society.
As a Technology Pioneer, Colossal will be invited to participate at World Economic Forum activities, events and discussions throughout the year. Colossal will also contribute to Forum initiatives over the next two years, working with global leaders to help address key industry and societal issues.
“We’re excited to welcome Colossal to our 2022 cohort of Technology Pioneers,” says Saemoon Yoon, Community Lead, Technology Pioneers, World Economic Forum. “Colossal and its fellow pioneers are at the forefront of industries that are critical to solving some of our world’s most complex issues today. We look forward to their contribution to the World Economic Forum in its commitment to improving the state of the world.”
Browse The Complete News About Aithority : oHouse Raises $182M Series D to Power the Global Adoption of its Lifestyle Super App
“We’re honored to share this distinction with fellow inventors working to preserve and protect life on Earth,” said Colossal Co-Founder and CEO Ben Lamm. “Never before has humanity had the power to repair the damage done to our ecosystem. Synthetic biology can reverse the staggering effects humans have had on biodiversity and climate, with additional positive implications for conservation, science, and humanity.”
Through collaboration with nonprofits, conservation groups and governments, Colossal aims to develop genetic toolkits and support DNA databases to aid in the restoration, diversification and rewilding of endangered species. Colossal is also developing software, wetware, and artificial wombs to advance these efforts as well as further developing human genetic technologies.
Read More About Aithority News : Unitas Global Acquires INAP’s Network Business Assets
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.